Clinical Report: Antimicrobial Resistance Among Pediatric Patients with Bloodstream Infections
Overview
This study evaluates trends in antimicrobial resistance (AMR) among pediatric patients with bloodstream infections (BSI) over a 20-year period in Stockholm, Sweden, and examines changes in antimicrobial prescription patterns at a hospital during the same timeframe.
Background
Bloodstream infections are a significant cause of morbidity and mortality in children, necessitating prompt empirical antimicrobial therapy. Antimicrobial resistance poses a critical threat to effective treatment. Surveillance of AMR is essential for informing clinical decision-making and public health policies.
Data Highlights
No numerical data was provided in the source material, which limits the ability to quantify trends in AMR and antibiotic use.
Key Findings
AMR has increased in Sweden over the last two decades despite a low overall prevalence.
Outpatient antibiotic sales for children have declined, particularly among those aged 0-4 years.
Hospitalized children show an increase in overall antibiotic consumption, contrasting with outpatient trends.
Data on pediatric AMR and antibiotic use in hospitalized children remain limited.
Six major bacterial pathogens account for a significant proportion of AMR-related deaths globally.
Clinical Implications
Continuous surveillance and tailored antibiotic stewardship programs are necessary to address rising resistance rates.
Conclusion
Monitoring AMR trends and antibiotic use in pediatric populations is important for enhancing treatment efficacy.
